Market Overview

7 Biggest Price Target Changes For Monday

Share:
  • Deutsche Bank raised the price target for Yum! Brands, Inc. (NYSE: YUM) from $75 to $82. Yum! Brands shares closed at $79.31 on Friday.
  • Cantor Fitzgerald boosted Moody's Corporation (NYSE: MCO) price target from $148 to $155. Moody's shares closed at $154.64 on Friday.
  • BMO Capital raised Twitter Inc (NYSE: TWTR) price target from $22 to $28. Twitter shares closed at $31.51 on Friday.
  • JP Morgan cut the price target for Expedia Inc (NASDAQ: EXPE) from $129 to $115. Expedia shares closed at $104.00 on Friday.
  • Credit Suisse lowered the price target for Genesee & Wyoming Inc (NYSE: GWR) from $94 to $80. Genesee & Wyoming shares closed at $69.59 on Friday.
  • JP Morgan boosted the price target on Humana Inc (NYSE: HUM) from $253 to $271. Humana shares closed at $265.32 on Friday.
  • Baird cut FedEx Corporation (NYSE: FDX) price target from $280 to $270. FedEx shares closed at $235.32 on Friday.

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (EXPE + FDX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AMTDMorgan StanleyUpgrades65.0
APOMorgan StanleyDowngrades34.0
ARMKBairdUpgrades44.0
CGMorgan StanleyDowngrades23.0
EIXEdward JonesDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

WWE Is Still A Heavyweight; KeyBanc Upgrades Stock Ahead Of TV Renewal Cycle

Teva's 'Achievable' 2018 Outlook, Restructuring Plan Trigger Credit Suisse Upgrade